CDC permits partial operations at DOD’s lead lab for medical biological defense research

The US Centers for Disease Control and Prevention (CDC) has approved reopening and partial operations of the US Army Medical Research Institute of Infectious Diseases (USAMRIID), the U.S. Department of Defense’s (DOD’s) lead laboratory for medical biological defense research. Over the summer, research was put on hold at the USAMRIID’s Fort Detrick, MD., location following a federal government-ordered shutdown that prompted a major reset of the institute’s biosafety program.

DoD Inspector General to Reevaluate Select Agent Facilities, Biosafety Oversight

The US Department of Defense (DoD) Office of the Inspector General is conducting a Follow-Up Evaluation of DoD Biological Select Agents and Toxins (BSAT) Biorisk Program Office implementation of recommendations from the April 2016 “Evaluation of DoD Biological Safety and Security Implementation.“

World Health Organization advisers call for registry of studies on human genome editing

A World Health Organization (WHO) advisory committee on editing human DNA will ask the United Nations agency to establish a global registry of all such research, recommend that editors of scientific journals not publish any unregistered studies, and ask science funders to require that their grantees register their studies.